<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Forest Laboratories Inc. | Company News & Executive Profiles - FRX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/forest+laboratories+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Forest Laboratories Inc.]]></description>
	<s:counts start="0" returned="10" found="59" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Justice eyes marketing at J&J, Forest]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/justice-eyes-marketing-forest/19742/]]></link>
		<description><![CDATA[It looks as if yet another U.S. drug-marketing investigation is about to be settled. As Dow Jones reports, Forest Laboratories has reached a tentative deal with the feds, which would settle civil allegations that it mismarketed antidepressants and a thyroid drug. But the deal wouldn't cover the government's "ongoing investigation...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Tue, 10 Nov 2009 09:10:19 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/investigation.html"><![CDATA[investigation]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">FRX,JNJ</category>
	</item>
	<item>
		<title><![CDATA[Forest Laboratories: Steady Growth in Sales and Earnings]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172192-forest-laboratories-steady-growth-in-sales-and-earnings%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[I have written about Forest Laboratories, Inc. FRX before. FRX is a mid-cap player in the biotech and drug markets. It is characterized by steady growth in both sales and earnings. Call this a value play. Its new product pipeline is promising, and several products are now entering Phase 3...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 09 Nov 2009 05:09:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/ron+sommer.html"><![CDATA[Ron Sommer]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest Laboratories Inc. F2Q10 (Qtr End 30/09/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-354431.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from the line of Rich Silver of Barclays Capital. Rich Silver - Barclays Capital  Hey Larry. Larry Olanoff  Good morning. Rich Silver - Barclays Capital  How are you? Larry Olanoff  Good. Thank you. Rich Silver -...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 20 Oct 2009 13:07:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/barclays+plc..html"><![CDATA[Barclays Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/daxas.html"><![CDATA[Daxas]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BCS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">BCS,FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest Labs Presents Encouraging Pneumonia Drug Data]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F161566-forest-labs-presents-encouraging-pneumonia-drug-data%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   We are pleased to hear that Forest Laboratories FRX presented encouraging data from its phase III trial of ceftaroline for the treatment of community-acquired pneumonia CAP in hospitalized patients. The company presented new data from two multicenter studies &#8211; FOCUS 1 and FOCUS 2 &#8211; at...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 15 Sep 2009 05:35:14 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest Lab's Hard Sell of Anti-Depressant Raises Questions]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159719-forest-lab-s-hard-sell-of-anti-depressant-raises-questions%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  Forest Labs FRX has done very, very well with Lexapro escitalopram over the years. They're a comparatively small company, and their collaboration with Lundbeck (HLUKY.PK) also a comparatively small company in the antidepressant field has been the biggest event in their history.    Lexapro...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 02 Sep 2009 11:27:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/derek+lowe.html"><![CDATA[Derek Lowe]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest?s COPD Drug Disappoints]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F157255-forests-copd-drug-disappoints%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   On Tuesday, Forest Laboratories FRX announced disappointing results from the mid-stage clinical trials of oglemilast, meant for chronic obstructive pulmonary disease COPD that usually affects smokers. The drug was being developed with Glenmark Pharmaceuticals S.A. Switzerland, a wholly owned unit of India-based Glenmark Pharmaceuticals. The phase...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 20 Aug 2009 04:48:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest Laboratories Inc. F1Q10 (Qtr End 06/30/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-323097.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions. And our first question comes from Tim Chiang with FTN Equity Capital. Tim Chiang - FTN Equity Capital I had a question about some of the guidance numbers that you provided last quarters and sort of given the strong uptake of Savella, why you're...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 21 Jul 2009 14:44:24 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/savella.html"><![CDATA[Savella]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest Laboratories Inc. F1Q10 (Qtr End 06/30/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F150286-forest-laboratories-inc-f1q10-qtr-end-06-30-09-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Forest Laboratories Inc. FRX   F1Q10 (Qtr End 06/30/09) Earnings Call   July 21, 2009 10:00 am ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 21 Jul 2009 03:44:24 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest Labs: Positive Top-Line Data on Ceftaroline]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145997-forest-labs-positive-top-line-data-on-ceftaroline%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Forest Laboratories, Inc. FRX announced positive results recently from two global multi-center phase III studies which were conducted to evaluate the efficacy, safety and tolerability of ceftaroline for the treatment of community-acquired bacterial pneumonia (CABP). by Zacks.com]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 29 Jun 2009 09:21:54 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
	<item>
		<title><![CDATA[Forest Labs: Concerned About Pipeline]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F143998-forest-labs-concerned-about-pipeline%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   By Jason Napodano, CFA & Brian Marckx, CFA Forest Laboratories, Inc.'s FRX financial results for 2009 were inline with our expectations. EPS fell 3% on revenue growth of 2% as operating cost growth outpaced that of revenue. SG&A expenses grew 10%, reflecting increased costs related to...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 18 Jun 2009 06:25:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/forest+laboratories+inc..html"><![CDATA[Forest Laboratories Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
		<category domain="tickers">FRX</category>
	</item>
</channel>
</rss>
